Portfolio
Latest Articles

MEDICINAL CANNABIS CBD AND HEMP PRODUCTS

CPH set to expand in $300M Latin American CBD market

Bod’s first sales in US a precursor for further revenue generation

April 7th 2021

Bod’s first sales in US a precursor for further revenue generation

Connect with us

EXPLORE

Finfeed Portfolio

Latest Articles

Archived Articles

About StocksDigital

PORTFOLIOS

Catalyst Hunter

STOCKS

FOLLOW OUR INVESTMENT COMMENTARY & ANALYSIS

CUSTOMER NOTICE | PRIVACY POLICY | FINANCIAL SERVICES GUIDE | DISCLOSURE POLICY

The information in this website is general information only. Any advice is general advice only. Your personal objectives, financial situation or needs have not been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice. S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877).

© 2021 | AFSL (CAR No.433913)